Harpoon Therapeutics, Inc. (HARP)’in fiyatı nedir?

Harpoon Therapeutics, Inc. (HARP)’in fiyatı $23.01’dir

Harpoon Therapeutics, Inc. (HARP)’in piyasa değeri nedir?

Harpoon Therapeutics, Inc. (HARP)’in piyasa değeri $74.80M’dir.

Harpoon Therapeutics, Inc. (HARP) F/S Oranı

Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to immunotherapy, focused on engineering a novel class of T cell activators. These therapies are designed to leverage the body's own immune system to fight cancer and other diseases in patients across the United States. The company's innovative Tri-specific T cell activating construct (TriTAC) platform forms the basis of its development pipeline. This includes HPN328, currently undergoing Phase I/II clinical trials for small cell lung cancer and tumors that express Delta-like canonical Notch ligand 3; HPN217, also in Phase I/II trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical evaluation for ovarian and pancreatic cancers, alongside other mesothelin-expressing tumors. Furthermore, Harpoon has a preclinical asset, HPN601, aimed at various solid tumor indications. The company has also established a discovery collaboration and licensing agreement with AbbVie Biotechnology Ltd. to develop and market products combining its unique TriTAC technology with soluble T cell receptors. Founded in 2015, Harpoon Therapeutics, Inc. is headquartered in South San Francisco, California.

Yıl	P/S Oranı	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

P/S Oranı

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	P/S Oranı	P/S Oranı Farkı	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	10.17	-	US
Argenx SE ARGX.US	10.13	-	NL
Moderna, Inc. MRNA.US	11.28	-	US
CSL Limited CSL.AX	2.95	-	AU
Lonza Group AG LONN.SW	-	-	CH

Şirket

P/S Oranı

P/S Oranı Farkı

Ülke